Multiplikator Forward P/S: Profusa (PFSA)
The P/S forward indicator in the GURU.Markets terminal confirms the scaling potential of Profusa Inc (PFSA) through the mass production of sensors and software, with the metric reaching the level of 0.00. Stable development is ensured by a strong staff of bioengineers and clinical experts. Profusa Inc (PFSA) creates unique implantable sensors that enable real-time, six-month monitoring of metabolites without tissue scarring.
Ringkesan rincian data analitis Profusa, Inc (PFSA)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Profusa Inc|PFSA - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Profusa Inc|PFSA - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Profusa, Inc|PFSA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Profusa|Rasio cepet profusa.com
- rincian asil keuangan lan kelipatan valuasi:
PFSA - Penghasilan resik perusahaan|Bathi sing dikarepake Profusa Inc|PFSA - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Profusa, Inc.|PFSA - Pangali PEG|Pangali EV/EBITDA Profusa, Inc|PFSA - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Profusa|PFSA - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan profusa.com|PFSA - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Profusa Inc
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:PFSA (Profusa)
For Profusa Inc (PFSA), whose proprietary biosensors create high customer lock-in through integration into medical systems, the forward price-to-sales ratio serves as an indicator of market expectations for technology commercialization. This chart compares current market capitalization with expected annual revenues, where daily recalculations filter out noise, allowing for the identification of fundamental undervaluation or overbought conditions during periods of volatility.
Karo sapa Profusa Inc saingan
Rasio rega marang prakiraan pendapatan Dexcom DXCM|PEN - Multiplikator forward rega marang pendapatan|Novanta Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Haemonetics Company|INSP: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PRCT|CNMD (CONMED) - Multiplikator Forward P/S|Pulse Biosciences Inc (PLSE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S INMD|Multiplikator forward rega marang pendapatan Picard Group PMI|Multiplikator Forward P/S SRDX (Surmodics, Inc.)|Multiplikator Forward P/S senseonics.com SENS|NPCE - Rasio rega marang prakiraan pendapatan|TCMD: Rasio rega marang prakiraan pendapatan|SNWV (SANUWAVE Health, Inc.) - Multiplikator forward rega marang pendapatan|Outset Medical Corp - Rega forward marang dodolan|ELMD (SmartVest) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep lensar.com LNSR|Rasio rega marang prakiraan pendapatan AVITA Medical (RCEL)|profoundmedical.com (PROF) - Prakiraan rega marang pendapatan|Baird Medical - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S EDAP TMS SA EDAP|Bovie Medical - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IceCure Medical Ltd ICCM|pulmonx.com (LUNG) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan TELA (TELA Bio)|Rasio rega marang prakiraan pendapatan CytoSorbents Corp|Multiplikator forward rega marang pendapatan Sensus (SRTS)|Multiplikator Forward P/S ZYXI|ECOR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Vicarious Surgical RBOT|IINN: Kapitalisasi marang prakiraan pendapatan|ICU: Multiplikator forward rega marang pendapatan|IRIDEX Corporation - Rasio rega marang pendapatan sing dikarepake|ibs.inc (INBS) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan XAIR (Beyond Air)|Rasio rega marang prakiraan pendapatan STRATA Skin Sciences Inc.|GCTK: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan NanoVibronix (NAOV)|VERO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S NUWE (Nuwellis, Inc.)|AEMD (aethlonmedical.com) - Rega mangsa ngarep marang pendapatan|ASXC: Multiplikator forward rega marang pendapatan|AVGR - Multiplikator Forward P/S|BioSig Technologies, Inc (BSGM) - Rasio rega marang prakiraan pendapatan|CUTR - Rasio kapitalisasi marang dodolan sing dikarepake|KNW (Know Labs, Inc.) - Multiplikator Forward P/S|Multiplikator Forward P/S inarimedical.com|Multiplikator forward rega marang pendapatan NVRO (Nevro)|RSLS (reshapelifesciences.com) - Rega forward marang dodolan|Multiplikator Forward P/S SILK (Silk Road Medical Inc.)
